• DotBio successfully raises $2.3 M in seed financing biospectrumasia
    August 08, 2018
    Newly formed company raises US$2.3 million seed financing led by HeungKong Group to complete validation studies of optimized, humanized domain antibodies and explore broad applicability of DotBody technology
PharmaSources Customer Service